Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates

Nature Protocols

Volumn 9, Issue 9, 2014, Pages 2135-2146

  Volpicelli Daley, Laura A ^a   Luk, Kelvin C ^b   Lee, Virginia M Y ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MULTIPROTEIN COMPLEX;

ANIMAL; BIOLOGICAL MODEL; CELL CULTURE TECHNIQUE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; LEWY BODY; METABOLISM; MOUSE; NEURITE; PROCEDURES; RAT;

ALPHA-SYNUCLEIN; ANIMALS; CELL CULTURE TECHNIQUES; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; LEWY BODIES; MICE; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; NEURITES; RATS;

EID: 84907033533     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2014.143     Document Type: Review

References (42)

1. McNaught, K.S., Shashidharan, P., Perl, D.P., Jenner, P. & Olanow, C.W. Aggresome-related biogenesis of Lewy bodies. Eur. J. Neurosci. 16, 2136-2148 (2002).
2. Kopito, R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524-530 (2000).
3. Kramer, M.L. & Schulz-Schaeffer, W.J. Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 27, 1405-1410 (2007).
4. Luk, K.C. & Lee, V.M. Modeling Lewy pathology propagation in Parkinson's disease. Parkinsonism Relat. Disord. 20 (suppl. 1), S85-S87 (2014).
5. Bendor, J.T., Logan, T.P. & Edwards, R.H. The function of α-synuclein. Neuron 79, 1044-1066 (2013).
6. Kaufman, S.K. & Diamond, M.I. Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics 10, 371-382 (2013).
7. George, S., Rey, N.L., Reichenbach, N., Steiner, J.A. & Brundin, P. α-Synuclein: the long distance runner. Brain Pathol. 23, 350-357 (2013).
8. Luk, K.C. et al. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. USA 106, 20051-20056 (2009).
9. Masliah, E. et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269 (2000).
10. Giasson, B.I. et al. Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein. Neuron 34, 521-533 (2002).
11. Lee, M.K. et al. Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. USA 99, 8968-8973 (2002).
12. Spillantini, M.G. et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251, 205-208 (1998).
13. Baba, M. et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879-884 (1998).
14. Fujiwara, H. et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160-164 (2002).
15. Volpicelli-Daley, L.A. et al. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57-71 (2011).
16. Desplats, P. et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein. Proc. Natl. Acad. Sci. USA 106, 13010-13015 (2009).
17. Frost, B., Jacks, R.L. & Diamond, M.I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845-12852 (2009).
18. Ren, P.H. et al. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol. 11, 219-225 (2009).
19. Tanik, S.A., Schultheiss, C.E., Volpicelli-Daley, L.A., Brunden, K.R. &Lee, V.M. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy. J. Biol. Chem. 288, 15194-15210 (2013).
20. Dryanovski, D.I. et al. Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J. Neurosci. 33, 10154-10164 (2013).
21. Taguchi, K. et al. Differential expression of α-synuclein in hippocampal neurons. PLoS ONE 9, e89327 (2014).
22. Buerli, T. et al. Efficient transfection of DNA or shRNA vectors into neurons using magnetofection. Nat. Protoc. 2, 3090-3101 (2007).
23. Zeitelhofer, M. et al. High-efficiency transfection of mammalian neurons via nucleofection. Nat. Protoc. 2, 1692-1704 (2007).
24. 2+-phosphate transfection efficiency in low-density neuronal cultures. Nat. Protoc. 1, 695-700 (2006).
25. Campenot, R.B., Lund, K. & Mok, S.A. Production of compartmented cultures of rat sympathetic neurons. Nat. Protoc. 4, 1869-1887 (2009).
26. Luk, K.C. et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949-953 (2012).
27. Beaudoin, G.M. III et al. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat. Protoc. 7, 1741-1754 (2012).
28. Seibenhener, M.L. & Wooten, M.W. Isolation and culture of hippocampal neurons from prenatal mice. J. Vis. Exp. doi:10.3791/3634 (26 July 2012).
29. Irwin, D.J. et al. Neuropathologic substrates of Parkinson disease dementia. Ann. Neurol. 72, 587-598 (2012).
30. Churchyard, A. & Lees, A.J. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology 49, 1570-1576 (1997).
31. Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211 (2003).
32. Banker, G.A. Trophic interactions between astroglial cells and hippocampal neurons in culture. Science 209, 809-810 (1980).
33. Bousset, L. et al. Structural and functional characterization of two α-synuclein strains. Nat. Commun. 4, 2575 (2013).
34. Murphy, D.D., Rueter, S.M., Trojanowski, J.Q. & Lee, V.M. Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214-3220 (2000).
35. Giasson, B.I., Murray, I.V., Trojanowski, J.Q. & Lee, V.M. A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276, 2380-2386 (2001).
36. Murray, I.V. et al. Role of α-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry 42, 8530-8540 (2003).
37. Fauvet, B. et al. α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J. Biol. Chem. 287, 15345-15364 (2012).
38. Conway, K.A., Harper, J.D. & Lansbury, P.T. Jr. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39, 2552-2563 (2000).
39. Kloepper, K.D., Woods, W.S., Winter, K.A., George, J.M. & Rienstra, C.M. Preparation of α-synuclein fibrils for solid-state NMR: expression, purification, and incubation of wild-type and mutant forms. Protein Expr. Purif. 48, 112-117 (2006).
40. Bellon, A. et al. Decontamination of prions in a plasma product manufacturing environment. Transfusion 54, 1028-1036 (2013).
41. Murphy, R.G. et al. Alkaline hydrolysis of mouse-adapted scrapie for inactivation and disposal of prion-positive material. J. Anim. Sci. 87, 1787-1793 (2009).
42. Luk, K.C. et al. Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice. J. Exp. Med. 209, 975-986 (2012).